Attivare Therapeutics
PrivateLast Round
Grant
Dec 15, 2025
Total Funding Raised
$12.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Attivare Therapeutics is a biotechnology company that develops personalized immunotherapies and vaccine platforms using a proprietary biomaterial scaffold technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attivare Therapeutics Comparables
Compare Attivare Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SURGE Therapeutics | 76% | |
| ImmunoVec | 71% | |
| Flashpoint Therapeutics | 70% | |
Attivare Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 15, 2025 | ||||
| Seed | Dec 2, 2021 |
Attivare Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Seed |
| Embark Ventures | Seed |
| AAF Management | Seed |
| Bill & Melinda Gates Foundation | Grant |
| Ulu Ventures | Seed |
| 8VC | Seed |
| Harmonix Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 15, 2025
Received $7M from the Bill & Melinda Gates Foundation.
- Dec 2, 2021
$6M round led by FundRx.
Attivare Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Attivare Therapeutics's valuation, stock price, and market status.